Literature DB >> 21606405

Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.

Johannes-Peter Stasch1, Pál Pacher, Oleg V Evgenov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21606405      PMCID： PMC3103045          DOI： 10.1161/CIRCULATIONAHA.110.981738

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  123 in total

1.  Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.

Authors:  R M Tuder; C D Cool; M W Geraci; J Wang; S H Abman; L Wright; D Badesch; N F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

2.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

3.  Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.

Authors:  J Galle; U Zabel; U Hübner; A Hatzelmann; B Wagner; C Wanner; H H Schmidt
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.

Authors:  A Mülsch; J Bauersachs; A Schäfer; J P Stasch; R Kast; R Busse
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

5.  YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.

Authors:  C M Teng; C C Wu; F N Ko; F Y Lee; S C Kuo
Journal:  Eur J Pharmacol       Date:  1997-02-12       Impact factor: 4.432

6.  Mechanism of YC-1-induced activation of soluble guanylyl cyclase.

Authors:  A Friebe; D Koesling
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

7.  Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Authors:  O Sitbon; M Humbert; J L Jagot; O Taravella; M Fartoukh; F Parent; P Herve; G Simonneau
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

8.  YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.

Authors:  A Friebe; F Müllershausen; A Smolenski; U Walter; G Schultz; D Koesling
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

9.  A comparative study of sildenafil, NCX-911 and BAY41-2272 on the anococcygeus muscle of diabetic rats.

Authors:  Jasjit S Kalsi; David J Ralph; David J Madge; Phil D Kell; Selim Cellek
Journal:  Int J Impot Res       Date:  2004-12       Impact factor: 2.896

10.  Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis.

Authors:  Volker O Melichar; Delphine Behr-Roussel; Ulrike Zabel; L Otto Uttenthal; José Rodrigo; Alain Rupin; Tony J Verbeuren; Arun Kumar H S; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205
View more
  191 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  Motion of proximal histidine and structural allosteric transition in soluble guanylate cyclase.

Authors:  Byung-Kuk Yoo; Isabelle Lamarre; Jean-Louis Martin; Fabrice Rappaport; Michel Negrerie
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

3.  Vasodilator responses to acetylcholine are not mediated by the activation of soluble guanylate cyclase or TRPV4 channels in the rat.

Authors:  Edward A Pankey; Modar Kassan; Soo-Kyoung Choi; Khalid Matrougui; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

4.  Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.

Authors:  Hema Kalyanaraman; Gerburg Schwaerzer; Ghania Ramdani; Francine Castillo; Brian T Scott; Wolfgang Dillmann; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  Diabetes       Date:  2018-01-04       Impact factor: 9.461

5.  Pharmacokinetic interaction study between riociguat and the combined oral contraceptives levonorgestrel and ethinylestradiol in healthy postmenopausal women.

Authors:  Reiner Frey; Sigrun Unger; Dorina van der Mey; Corina Becker; Soundos Saleh; Georg Wensing; Wolfgang Mück
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

6.  Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.

Authors:  Xiaojian Xu; Shumin Wang; Juan Liu; Dou Dou; Limei Liu; Zhengju Chen; Liping Ye; Huixia Liu; Qiong He; J Usha Raj; Yuansheng Gao
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

7.  Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.

Authors:  Nathaniel B Fernhoff; Emily R Derbyshire; Eric S Underbakke; Michael A Marletta
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

8.  Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics.

Authors:  Margarete von Wantoch Rekowski; Vijay Kumar; Focco van den Akker; Athanassios Giannis; Andreas Papapetropoulos; Zongmin Zhou; Johann Moschner; Antonia Marazioti; Marina Bantzi; Georgios A Spyroulias
Journal:  J Med Chem       Date:  2013-10-24       Impact factor: 7.446

9.  The sGC activator BAY 60-2770 has potent erectile activity in the rat.

Authors:  George F Lasker; Edward A Pankey; Terrence J Frink; Jonathan R Zeitzer; Korey A Walter; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

10.  A molecular mechanism for therapeutic effects of cGMP-elevating agents in pulmonary arterial hypertension.

Authors:  Raphaela Schwappacher; Ana Kilic; Baktybek Kojonazarov; Michaela Lang; Thuan Diep; Shunhui Zhuang; Thomas Gawlowski; Ralph T Schermuly; Alexander Pfeifer; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.